Joint damage and chronic pain persist in hemophilia, especially in low-resource settings, necessitating innovative therapies and early diagnostic tools. Extended half-life products and emerging ...
Many boys with hemophilia play sports regularly, but frequent activity may raise the risk of sports-induced bleeding, a study ...
What Is Alhemo, and Why Does It Matter? Alhemo (concizumab-mtci) is a medicine approved to help prevent bleeding in people aged 12 or older with hemophilia A or B who don’t have inhibitors to certain ...
Blood clotting represents one of the body’s most elegant and complex protective mechanisms. This intricate process involves numerous proteins working in precise sequence – often described as a ...
Hemophilia A is a rare, inherited condition that prevents your blood from clotting the way it should. People with hemophilia A do not make enough of a protein called factor VIII, which normally works ...
Currently, India’s health care approach to hemophilia is largely episodic. We wait for the disaster to happen. This is not health care; it is crisis management ...
Many people with hemophilia A can lead ordinary, active lives. Learning more about this genetic condition can support effective long-term management strategies. Hemophilia A is a genetic condition ...
Hemophilia, von Willebrand disease, anemia, leukemias, or a low platelet count can cause bruising. A person should contact a doctor if they are concerned about their bruising. Bruising is one of the ...
Dose and frequency should be adjusted based on antithrombin activity, using the Innovance Antithrombin companion diagnostic test. The Food and Drug Administration (FDA) has approved Qfitlia (fitusiran ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results